Neautech Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neautech Inc. - overview
Established
2022
Location
Tokyo, -, Japan
Primary Industry
Healthcare IT
About
Based in Tokyo, Japan, and founded in 2022, Neautech Inc. operates an online skincare clinic focused on promoting aesthetic medicine. In October 2025, Neautech Inc. raised an undisclosed amount in series B funding from returning investor Beyond Next Ventures, with participation from new investors SBI Investment, and Deepcore.
This round was part of a larger JPY 1. 12 billion series B equity and venture debt funding. Neautech Inc. provides Hada Lounge clinic, a flat-rate beauty dermatology clinic that offers online medical examination, chat skin care consultation room, delivery of skin care prescription drugs, and treatment in collaboration with beauty dermatology.
It is a prescription service. The company also engages in influencer business related to aesthetic medicine and beauty care. The company will use the October 2025 funding to enhance companion treatment with generative artificial intelligence, expand physician and customer success teams, and invest in branding.
Current Investors
Beyond Next Ventures, SBI Investment, Deepcore
Primary Industry
Healthcare IT
Sub Industries
Beauty & Hygiene, Aesthetic Medicine, Healthcare IT, Dermatology
Website
www.neautech.jp
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.